enkephalin, leucine has been researched along with istradefylline in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aoyama, S; Borrelli, E; Kase, H | 1 |
Aoyama, S; Kase, H; Kobayashi, H; Koga, K; Kuwana, Y; Miyaji, H; Mori, A; Sekine, S; Uchimura, T | 1 |
Cenci, MA; Lundblad, M; Vaudano, E | 1 |
Chan, P; Chen, JF; Chen, L; Chen, X; Feng, Y; Gao, Y; Guo, W; He, Y; Li, F; Li, Y; Li, Z; Ren, X; Wang, T; Xue, J; Ye, F; Zhang, L; Zheng, W | 1 |
4 other study(ies) available for enkephalin, leucine and istradefylline
Article | Year |
---|---|
Rescue of locomotor impairment in dopamine D2 receptor-deficient mice by an adenosine A2A receptor antagonist.
Topics: Adenosine; Animals; Antihypertensive Agents; Antineoplastic Agents; Enkephalins; Gait; Gene Expression; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Parkinson Disease, Secondary; Phenethylamines; Purinergic P1 Receptor Antagonists; Purines; Radioligand Assay; Receptor, Adenosine A2A; Receptors, Dopamine D2; Receptors, Purinergic P1; RNA, Messenger; Substance P; Tritium | 2000 |
Distribution of adenosine A(2A) receptor antagonist KW-6002 and its effect on gene expression in the rat brain.
Topics: Administration, Oral; Adrenergic Antagonists; Animals; Carbon Radioisotopes; Corpus Striatum; Enkephalins; Gene Expression; Male; Neurons; Oxidopamine; Parkinsonian Disorders; Protein Precursors; Purinergic P1 Receptor Antagonists; Purines; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; RNA, Messenger; Sympatholytics; Tachykinins; Tissue Distribution | 2002 |
Cellular and behavioural effects of the adenosine A2a receptor antagonist KW-6002 in a rat model of l-DOPA-induced dyskinesia.
Topics: Animals; Behavior, Animal; Corpus Striatum; Disease Models, Animal; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Enkephalins; Female; Levodopa; Motor Activity; Oxidopamine; Parkinsonian Disorders; Protein Precursors; Proto-Oncogene Proteins c-fos; Purinergic P1 Receptor Antagonists; Purines; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; RNA, Messenger; Treatment Outcome | 2003 |
The Corticostriatal Adenosine A
Topics: Action Potentials; Adenosine A2 Receptor Antagonists; Animals; Corpus Striatum; Disease Models, Animal; Enkephalins; Female; Macaca fascicularis; Male; Maze Learning; Memory Disorders; Memory, Short-Term; Mice; Mice, Inbred C57BL; Mice, Transgenic; MPTP Poisoning; Nerve Tissue Proteins; Prefrontal Cortex; Purines; Receptor, Adenosine A2A; Spatial Memory | 2018 |